Insulet (PODD) Selling, General & Administrative (2010 - 2026)
Insulet (PODD) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Insulet | 10.27 Bn | 9.74 Bn | 562.60 Mn | 344.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 344.80 Mn |
| Mar 31, 2026 | 317.20 Mn |
| Dec 31, 2025 | 331.40 Mn |
| Sep 30, 2025 | 315.20 Mn |
| Jun 30, 2025 | 257.70 Mn |
| Mar 31, 2025 | 260.70 Mn |
| Dec 31, 2024 | 260.90 Mn |
| Sep 30, 2024 | 234.10 Mn |
| Jun 30, 2024 | 222.50 Mn |
| Mar 31, 2024 | 199.70 Mn |
| Dec 31, 2023 | 212.70 Mn |
| Sep 30, 2023 | 180.70 Mn |
| Jun 30, 2023 | 178.70 Mn |
| Mar 31, 2023 | 162.70 Mn |
| Dec 31, 2022 | 144.30 Mn |
| Sep 30, 2022 | 140.40 Mn |
| Jun 30, 2022 | 174.40 Mn |
| Mar 31, 2022 | 128.70 Mn |
| Dec 31, 2019 | 215.44 Mn |
| Sep 30, 2019 | 27.55 Mn |